Polymorphic changes in the 5′ flanking region of Factor VII have a combined effect on promoter strength

Rama Kudaravalli, Theresa Tidd, Mirko Pinotti, Antonia Ratti, Rosa Santacroce, Maurizio Margaglione, Bruno Dallapiccola, Francesco Bernardi, Paolo Fortina, Marcella Devoto, Eleanor S. Pollak

Research output: Contribution to journalArticlepeer-review


Polymorphic differences in the 5′ flanking region of the gene encoding procoagulant protein Factor VII (FVII) are associated with variations in FVII coagulant activity (FVII:C) and FVII antigen (FVII:Ag) levels. A decanucleotide insert polymorphism (CCTATATCCT) at 323 bp upstream of the start site of translation correlates with a decrease of approximately 20% FVII:C levels per allele containing this insert. However, linkage disequilibrium of the decanucleotide polymorphism with two single nucleotide polymorphisms (SNPs) at -122 and -401 have made it difficult to pinpoint the functional role, if any, of these genetic changes in lowering FVII levels. In vitro reporter gene studies in HepG2 cells analyzing the 8 possible combinations of polymorphic sites at -401, -323, and -122 reveal the necessity of the presence of the three concurrent polymorphic changes to maximally decrease promoter strength. In addition, these in vitro results are supported by in vivo studies in 89 individuals of African heritage, 34% of whom display a new haplotype that shows the polymorphic changes at -323 and -401 but lacks the change at -122.

Original languageEnglish
Pages (from-to)763-767
Number of pages5
JournalThrombosis and Haemostasis
Issue number5
Publication statusPublished - Nov 1 2002


  • African American
  • Decanucleotide
  • Factor VII
  • Polymorphism
  • Transcription

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Polymorphic changes in the 5′ flanking region of Factor VII have a combined effect on promoter strength'. Together they form a unique fingerprint.

Cite this